A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...

The deal with U.S. biotech Septerna will see the companies develop pills to treat obesity, type 2 diabetes and other ...

Attention-deficit/hyperactivity disorder (ADHD) might contribute to obesity by reducing physical activity—a relationship that ...

At Hospital Raja Permaisuri Bainun (HRPB) in Ipoh, bariatric surgery is transforming lives, providing a lifeline to ...

Learn about SYNT-101, the emerging treatment for obesity that combines the best of two proven methods.

Queen Latifah opens up about obesity and heart health risks for public awareness campaign, Truth About Weight.

Deaths attributed to both acute heart attack and obesity rose between 2007 and 2019, according to findings from the CDC ...

Childhood obesity is a growing concern. A recent study highlights the link between belly fat in kids and heart disease risks.

Successfully treating type 2 diabetes may involve focusing on brain neurons, rather than simply concentrating on obesity or insulin resistance, according to a study published today in the Journal of ...

Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...

Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...

Adults with a mental illness experienced weight loss and glycemic benefits with use of a GLP-1 without worsening of mental ...